Impact BioMedical, Inc. (IBO) Balance Sheet
IBO balance sheet, 2025
December 31, 2025 · U.S. dollars$17.4M assets = $1.9M liabilities + $15.6M equity
Both columns are drawn to the same scale: what IBO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
IBO financial health
Descriptive bands, not a rating. Fiscal 2025.
IBO balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $405,6002016 | $17.4M2025 | +51.8%/yr | |
| Total liabilities | $5,6002016 | $1.9M2025 | +90.5%/yr | |
| Shareholders’ equity | $400,0002016 | $12.6M2025 | +46.7%/yr | |
| Cash & short-term investments | $387,7502016 | $3,0002025 | −41.7%/yr | |
| Total debt | $1.1M2020 | $621,0002025 | −10.1%/yr | |
| Net cash (debt) | −$986,8822020 | −$618,0002025 | +$368,882 | |
| Working capital | $400,0002016 | −$751,0002025 | −$1.2M | |
| Book value per share | $0.032017 | $5.042025 | +90.6%/yr | |
| Current ratio | 72.432016 | 0.352025 | −72.07 | |
| Debt / equity | 0.032020 | 0.052025 | +0.02 | |
| Shares outstanding | 10.2M2017 | 2.5M2025 | −16.1%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
IBO assets
IBO liabilities and equity
IBO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
IBO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $3,000 | $2.0M | $1,000 | $2,000 | $46,000 | $72,347 | $97,666 | $204,929 | $51,922 | $387,750 |
| Cash & equivalents | $3,000 | $2.0M | $1,000 | $2,000 | $46,000 | $72,347 | $97,666 | $204,929 | $51,922 | $387,750 |
| Short-term investments | — | $2.0M | — | — | — | — | — | — | — | — |
| Receivables | $203,000 | $184,000 | $331,000 | $16,000 | $197,000 | $14,063 | $35,191 | $4,378 | $28,619 | $850 |
| Inventory | $63,000 | −$265 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $142,000 | $265,265 | $0 | $104,000 | $44,000 | $20,937 | $0 | $7,900 | $240,120 | $17,000 |
| Total current assets | $411,000 | $2.4M | $332,000 | $122,000 | $287,000 | $107,347 | $115,341 | $217,207 | $320,661 | $405,600 |
| Property, plant & equipment (net) | $0 | $17,000 | $287,000 | $276,000 | $3.0M | $1,045 | $1,274 | $0 | $0 | $0 |
| Goodwill & intangible assets | $17.0M | $35.6M | $44.0M | $45.1M | $46.2M | $47.4M | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $782,000 | $4.8M | $632,100 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $190,000 | $2.0M | $0 | $0 | $0 | $0 | $0 |
| Total assets | $17.4M | $20.3M | $44.6M | $46.5M | $56.4M | $48.1M | $116,615 | $217,207 | $320,661 | $405,600 |
| Liabilities | ||||||||||
| Accounts payable | $347,000 | $314,000 | $832,000 | $539,000 | $115,000 | $9,267 | — | — | — | — |
| Short-term debt | $621,000 | $8.9M | $12.1M | $10.0M | $12.5M | $1.1M | — | — | — | — |
| Deferred revenue | — | — | — | $165,900 | $290,891 | — | — | — | — | — |
| Total current liabilities | $1.2M | $9.8M | $13.1M | $10.6M | $12.6M | $1.1M | $21,724 | $20,092 | $25,437 | $5,600 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $688,000 | $3.3M | $3.2M | $3.2M | $3.9M | $5.3M | $0 | $0 | $0 | $0 |
| Total liabilities | $1.9M | $13.1M | $16.4M | $13.8M | $16.5M | $6.3M | $21,724 | $20,092 | $25,437 | $5,600 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $105,000 | $11,000 | $10,000 | $70,000 | $125,000 | $125,073 | $619,104 | $595,513 | $595,513 | $400,000 |
| Retained earnings (deficit) | −$49.5M | −$37.7M | −$13.0M | −$8.6M | −$1.6M | −$271,224 | −$624,707 | −$506,398 | −$408,289 | — |
| Accumulated other comprehensive income | — | — | $0 | $3.9M | $1.4M | $0 | — | — | — | — |
| Minority interest | $2.9M | $3.0M | $3.0M | $3.1M | — | — | — | — | — | — |
| Total shareholders' equity | $12.6M | $4.3M | $25.2M | $29.6M | $36.6M | $37.9M | $94,891 | $197,115 | $295,224 | $400,000 |
| Key figures | ||||||||||
| Total debt | $621,000 | $8.9M | $12.1M | $10.0M | $12.5M | $1.1M | — | — | — | — |
| Net cash (debt) | −$618,000 | −$6.9M | −$12.1M | −$10.0M | −$12.5M | −$986,882 | — | — | — | — |
| Working capital | −$751,000 | −$7.3M | −$12.8M | −$10.5M | −$12.4M | −$961,418 | $93,617 | $197,115 | $295,224 | $400,000 |
| Tangible book value | −$4.4M | −$31.3M | −$18.8M | −$15.6M | −$9.6M | −$9.4M | $94,891 | $197,115 | $295,224 | $400,000 |
| Book value per share | $5.04 | $1.29 | $5.28 | — | — | — | $0.01 | $0.02 | $0.03 | — |
| Shares outstanding | 2.5M | 3.3M | 4.8M | — | — | — | 11.8M | 9.8M | 10.2M | — |
| Current ratio | 0.35 | 0.25 | 0.03 | 0.01 | 0.02 | 0.10 | 5.31 | 10.81 | 12.61 | 72.43 |
| Quick ratio | 0.18 | 0.22 | 0.03 | 0.00 | 0.02 | 0.08 | 6.12 | 10.42 | 3.17 | 69.39 |
| Debt / equity | 0.05 | 2.08 | 0.48 | 0.34 | 0.34 | 0.03 | — | — | — | — |
| Equity / assets | 72.4% | 21.0% | 56.5% | 63.6% | 64.9% | 78.8% | 81.4% | 90.7% | 92.1% | 98.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $10,000 | $20,000 | $3,000 | $12,000 | $624,000 | $1.3M | $2.0M | $2.7M | $2,000 | $2,000 | $1,000 | $201,000 |
| Cash & equivalents | $10,000 | $20,000 | $3,000 | $12,000 | $624,000 | $1.3M | $2.0M | $2.7M | $2,000 | $2,000 | $1,000 | $201,000 |
| Receivables | $197,000 | $199,000 | $203,000 | $214,000 | $200,000 | $204,000 | $184,000 | $142,000 | $263,000 | $331,000 | $331,000 | $204,000 |
| Inventory | $62,000 | $63,000 | $63,000 | $485,000 | $486,000 | $489,000 | $0 | $0 | $0 | $0 | $0 | $5 |
| Other current assets | $51,000 | $95,000 | $142,000 | $206,000 | $171,000 | $172,000 | $265,000 | $365,000 | $42,000 | $2,000 | $0 | $95,995 |
| Total current assets | $320,000 | $377,000 | $411,000 | $917,000 | $1.5M | $2.2M | $2.4M | $3.2M | $307,000 | $335,000 | $332,000 | $501,000 |
| Property, plant & equipment (net) | $0 | $0 | $0 | $13,000 | $14,000 | $16,000 | $17,000 | $282,000 | $284,000 | $285,000 | $287,000 | $289,000 |
| Goodwill & intangible assets | $16.4M | $16.7M | $17.0M | $17.3M | $17.6M | $17.9M | $22.3M | $43.2M | $43.5M | $43.7M | $44.0M | $44.3M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $59,000 | $67,000 | $0 | $0 | $0 |
| Total assets | $16.7M | $17.1M | $17.4M | $18.2M | $19.1M | $20.1M | $20.3M | $46.7M | $44.1M | $44.4M | $44.6M | $45.1M |
| Liabilities | ||||||||||||
| Accounts payable | $467,000 | $374,000 | $347,000 | $576,000 | $554,000 | $615,000 | $314,000 | $1.0M | $986,000 | $1.0M | $832,000 | $476,000 |
| Short-term debt | — | — | $621,000 | $22.9M | $22.4M | $9.1M | $8.9M | $35,000 | $13.5M | $12.8M | $12.1M | $11.8M |
| Total current liabilities | $2.0M | $1.7M | $1.2M | $23.8M | $23.2M | $10.0M | $9.8M | $1.1M | $14.5M | $13.9M | $13.1M | $12.3M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8.0M | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $688,000 | $688,000 | $688,000 | $3.3M | $3.3M | $3.3M | $3.3M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M |
| Total liabilities | $2.7M | $2.4M | $1.9M | $27.1M | $26.4M | $13.2M | $13.1M | $12.3M | $17.7M | $17.1M | $16.4M | $15.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $108,000 | $108,000 | $105,000 | $12,000 | $12,000 | $12,000 | $11,000 | $11,000 | $10,000 | $10,000 | $10,000 | $70,000 |
| Retained earnings (deficit) | −$52.5M | −$51.8M | −$49.5M | −$54.8M | −$53.3M | −$38.9M | −$37.7M | −$10.6M | −$14.8M | −$13.9M | −$13.0M | −$11.7M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | $0 | $0 | $0 | — |
| Minority interest | $3.2M | $3.2M | $2.9M | $3.0M | $3.0M | — | — | — | — | — | — | — |
| Total shareholders' equity | $10.8M | $11.5M | $12.6M | −$11.8M | −$10.3M | $3.8M | $4.3M | $31.3M | $23.4M | $24.3M | $25.2M | $26.5M |
| Key figures | ||||||||||||
| Total debt | — | — | $621,000 | $22.9M | $22.4M | $9.1M | $8.9M | $8.0M | $13.5M | $12.8M | $12.1M | $11.8M |
| Net cash (debt) | — | — | −$618,000 | −$22.9M | −$21.7M | −$7.8M | −$6.9M | −$5.3M | −$13.4M | −$12.8M | −$12.1M | −$11.6M |
| Working capital | −$1.7M | −$1.3M | −$751,000 | −$22.9M | −$21.7M | −$7.8M | −$7.3M | $2.0M | −$14.2M | −$13.5M | −$12.8M | −$11.8M |
| Tangible book value | −$5.7M | −$5.2M | −$4.4M | −$29.1M | −$27.9M | −$14.0M | −$18.0M | −$11.8M | −$20.1M | −$19.5M | −$18.8M | −$17.8M |
| Book value per share | $1.26 | $1.34 | $5.04 | — | — | — | — | $5.49 | — | — | — | — |
| Shares outstanding | 8.5M | 8.5M | 2.5M | — | — | — | — | 5.7M | — | — | — | — |
| Current ratio | 0.16 | 0.22 | 0.35 | 0.04 | 0.06 | 0.22 | 0.25 | 2.79 | 0.02 | 0.02 | 0.03 | 0.04 |
| Quick ratio | 0.10 | 0.13 | 0.18 | 0.01 | 0.04 | 0.15 | 0.22 | 2.47 | 0.02 | 0.02 | 0.03 | 0.03 |
| Debt / equity | — | — | 0.05 | — | — | 2.38 | 2.08 | 0.26 | 0.58 | 0.53 | 0.48 | 0.44 |
| Equity / assets | 64.3% | 67.1% | 72.4% | −64.9% | −54.3% | 19.2% | 21.0% | 67.1% | 53.0% | 54.7% | 56.5% | 58.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 11, 2026); data from EODHD.
IBO financial position
At the end of fiscal 2025 (December 31, 2025), Impact BioMedical had total assets of $17.4 million (down 14.2% from a year earlier), total liabilities of $1.9 million and shareholders' equity of $12.6 million. It held $0.0 million in cash and short-term investments against $0.6 million of debt, net debt of $0.6 million. Its current ratio was 0.35. In the latest quarter (ended June 30, 2026) total assets were $16.7 million and equity $10.8 million.
Related: IBO income statement, IBO cash flow statement, IBO key metrics. See the IBO stock overview for the latest quote and news.
IBO balance sheet FAQ
What are Impact BioMedical's total assets?
Impact BioMedical reported total assets of $17.4 million at the end of fiscal 2025 (December 31, 2025), compared with $20.3 million a year earlier.
How much debt does Impact BioMedical have?
Impact BioMedical had $0.6 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.05.
How much cash does Impact BioMedical have?
Impact BioMedical held $0.0 million in cash and short-term investments at the end of fiscal 2025; with $0.6 million of debt that is net debt of $0.6 million.
What is Impact BioMedical's book value?
Impact BioMedical's shareholders' equity (book value) was $12.6 million at the end of fiscal 2025, or $5.04 per share.
What is Impact BioMedical's current ratio?
Impact BioMedical had current assets of $0.4 million and current liabilities of $1.2 million, a current ratio of 0.35 (current liabilities exceed current assets).
How much goodwill does Impact BioMedical have?
Impact BioMedical carried $17.0 million of goodwill and intangible assets, 97.6% of total assets, at the end of fiscal 2025.